Rocket Pharmaceuticals, Inc. Other Noncash Expense
Rocket Pharmaceuticals, Inc. (RCKT) reported Other Noncash Expense of $274.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2015-05-14
- Rocket Pharmaceuticals, Inc. other noncash expense for the quarter ending 2015-03-31 was $274.00K, a 437.25% increase year-over-year.
- Rocket Pharmaceuticals, Inc. other noncash expense for the quarter ending 2014-03-31 was $51.00K.
| Period end | Other Noncash Expense 3 month |
|---|---|
| 2015-03-31 | $274.00K 10-Q · filed 2015-05-14 |
| 2014-03-31 | $51.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |